U.S. pharma stocks extend gains, AstraZeneca jumps more than 6% after earnings
U.S. pharmaceutical stocks continued to rise, according to MSX.COM data, with AstraZeneca leading the move after posting quarterly results. The company climbed more than 6% after its earnings release, as third-quarter profit came in above expectations. Other major drugmakers also advanced during the session. Eli Lilly and Gilead Sciences each gained more than 4%, while Amgen rose nearly 3% and Johnson & Johnson added close to 2%. The report said all of these stocks hit record highs intraday. The move kept the broader healthcare and pharmaceutical segment on an upward track in U.S. equities.



